Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

425 ARTÍCULOS , VIENDO DEL 376 AL 390

Nanotechnology-driven approaches for the early detection and targeted treatment of Alzheimer's disease

Sharma DK.

J Drug Target. 2026 Mar;34(3):372-389. doi: 10.1080/1061186X.2025.2561788. Epub 2025 Sep 19.

Behavioral dyadic interventions in the context of Alzheimer's disease and related dementia: A call to action

Vranceanu AM, Szapary CL, Cornelius T, Monin JK, Syme M, Okereke OI, Lyons KS, Plys E.

J Alzheimers Dis. 2026 Jan;109(1):34-43. doi: 10.1177/13872877251392184. Epub 2025 Nov 10.

A review of deep learning techniques in Alzheimer's disease with emphasis on data tools and transfer learning

Mehmood A, Shahid F, Khan R, AlZu'bi H.

Neuroscience. 2026 Jan 26;593:242-254. doi: 10.1016/j.neuroscience.2025.12.032. Epub 2025 Dec 14.

Need for analysis of linguistic factors for elucidating the pathogenesis of Alzheimer's disease: A position paper

Yokoi T.

J Alzheimers Dis. 2026 Feb;109(4):1603-1607. doi: 10.1177/13872877251407350. Epub 2025 Dec 19.

Magnetic resonance imaging analysis for Alzheimer's disease diagnosis using artificial intelligence: Methods, challenges, and opportunities

Shi Q, Hou J, Peng X, Xu Z, Wang Y, Cao D.

Ageing Res Rev. 2026 Jan;113:102943. doi: 10.1016/j.arr.2025.102943. Epub 2025 Nov 19.

Clinical and functional evidence supporting the pathogenicity of the novel PSEN1 p.R358P variant in early-onset Alzheimer's disease

García-Chialva DE, Itzcovich T, Cifarelli D, Apecetche M, Chrem-Méndez P, Magrath-Guimet N, Vazquez S, Bérgamo Y, Allegri R, Marazita M, Sevlever GE, Isaja L, Surace EI, Romorini L.

J Alzheimers Dis. 2026 Jan;109(1):114-124. doi: 10.1177/13872877251392236. Epub 2025 Nov 6.

A unified 3D reconstruction of microscopy and MRI in a brain showing Alzheimer's disease-related neuropathology

Alkemade A, Bazin PL, Kirilina E, Pine K, Herrler A, Bleijs RLAW, Kros JM, Groenewegen L, Vermorgen SMM, Jonkman LE, Swaab DF, Balesar R, Weiskopf N, Forstmann BU.

Brain Pathol. 2026 Mar;36(2):e70039. doi: 10.1111/bpa.70039. Epub 2025 Sep 11.

Paratonia in dementia: diagnosis and management strategies

Joshi S, Chutia P, Tripathi SM.

Neurodegener Dis Manag. 2026 Apr;16(2):173-176. doi: 10.1080/17582024.2025.2591413. Epub 2025 Nov 18.

Challenging the boundaries: c9orf72 mutation presenting as Alzheimer's disease

Garrou F, De Marchi F, Corrado L, Sacchetti GM, D'alfonso S, Morbelli SD, Perani D, Mazzini L, Tondo G.

Amyotroph Lateral Scler Frontotemporal Degener. 2026 Feb;27(1-2):215-218. doi: 10.1080/21678421.2025.2541761. Epub 2025 Aug 6.

Severe symptomatic amyloid-related imaging abnormalities in Alzheimer's disease: Two case reports and systematic review of reported cases

Villarejo Galende A, González-Sánchez M, Hilario A, Llamas-Velasco S, Morenas-Rodríguez E, Muñoz-García MI, Ramos-González A, Pérez-Martínez DA, Blanco-Palmero VA.

J Alzheimers Dis. 2026 Feb;109(3):1099-1116. doi: 10.1177/13872877251404505. Epub 2025 Dec 12.

Efficacy and Safety of Gantenerumab in Patients With Alzheimer Disease: A Systematic Review and Meta-analysis

Alla D, Malireddi A, Ramsundar R, Shah D, Alla SSM, Das A, Andanappa A, Emmanuel NW, Siddiqui S, Marepalli NR, Dugyala RR, Kolte R.

Clin Neuropharmacol. 2026 Jan-Feb 01;49(1):4-10. doi: 10.1097/WNF.0000000000000661. Epub 2025 Nov 24.

Liraglutide in mild to moderate Alzheimer's disease: a phase 2b clinical trial

Edison P, Femminella GD, Ritchie C, Nowell J, Holmes C, Walker Z, Ridha B, Raza S, Livingston NR, Frangou E, Love S, Williams G, Lawrence R, Mcfarlane B, Archer H, Coulthard E, Underwood BR, Koranteng P, Karim S, Bannister C, Perneczky R, Prasanna A, Junaid K, McGuinness B, Nilforooshan R, Macharouthu A, Donaldson A, Thacker S, Russell G, Malik N, Mate V, Knight L, Kshemendran S, Holscher C, Mansouri A, Chester-Jones M, Holmes J, Tan T, Williams S, Ashraf A, Brooks DJ, Harrison J, Hinz R, Tadros G, Passmore AP, Ballard C.

Nat Med. 2026 Jan;32(1):353-361. doi: 10.1038/s41591-025-04106-7. Epub 2025 Dec 1.

Donanemab in early symptomatic Alzheimer's disease: results from the TRAILBLAZER-ALZ 2 long-term extension

Zimmer JA, Sims JR, Evans CD, Nery ESM, Wang H, Wessels AM, Tronchin G, Sato S, Raket LL, Andersen SW, Sapin C, Paget MA, Gueorguieva I, Ardayfio P, Khanna R, Brooks DA, Matthews BR, Mintun MA; Alzheimer’s Disease Neuroimaging Initiative.

J Prev Alzheimers Dis. 2026 Feb;13(2):100446. doi: 10.1016/j.tjpad.2025.100446. Epub 2025 Dec 1.

Inflammation as a mediator of air pollution's role in Alzheimer's disease and related dementias

Zhao B, Geng C, Zhou S, Wei T, Li A, Zhao Y, Tang Y.

J Alzheimers Dis. 2026 Feb;109(4):1649-1662. doi: 10.1177/13872877251408422. Epub 2025 Dec 29.

Unveiling Alzheimer's disease (1901-2025): Historical insights, global burden, biological mechanisms, diagnostics, and therapeutic strategies

Baviskar PS, Mahajan HS.

Ageing Res Rev. 2026 Jan;114:102990. doi: 10.1016/j.arr.2025.102990. Epub 2025 Dec 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias